AMBER PARKS: Open Payments
NPI 1922600568 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 55 payments from 18 companies in 2025. Trend: 2023 $52 · 2024 $0 · 2025 $1,598
Food & beverage: $1,598
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $374 |
| Verona Pharma, Inc. | 3 | $217 |
| Regeneron Healthcare Solutions, Inc. | 7 | $139 |
| GlaxoSmithKline, LLC. | 6 | $120 |
| United Therapeutics Corporation | 2 | $116 |
| GENZYME CORPORATION | 4 | $97 |
| Merck Sharp & Dohme LLC | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Electromed, Inc. | 6 | $69 |
| Viatris Specialty LLC | 2 | $47 |
Products named: TEZSPIRE, DUPIXENT, Ohtuvayre, TYVASO, ZERBAXA, TRELEGY ELLIPTA, GLASSIA, SMARTVEST.
Industry payments across AZ — which companies pay providers there.
